Filter

151 - 160 of 1,231 Results

  • As Congress Considers Reauthorization of PEPFAR, KFF Examines the Role of Abortion

    News Release

    As Congress considers reauthorization of the President’s Emergency Plan for AIDS Relief (PEPFAR) for a fourth time, KFF explores the debate over abortion policy that has stalled the legislation and the potential implications if Congress does not reauthorize the program. PEPFAR spans more than 50 countries and has been reported to have saved 25 million lives since President George W. Bush created it in 2003. Funding for the program in FY 2023 was $6.9 billion,…

  • News Release

    KFF Research Shows that Medicare Open Enrollment TV Ads Are Dominated by Medicare Advantage Plans Featuring Celebrities, Active and Fit Seniors, and Promises of Savings and Extra Benefits Without Fundamental Plan Information

    News Release

    The annual blitz of ads for Medicare Advantage plans has become a rite of fall, as health insurers, brokers and other third parties seek to court enrollees for these private plans, which are offered to the 65 million people with Medicare during the program’s open enrollment season. In advance of the open enrollment period starting on October 15, KFF reviewed more than 1,200 unique television ads that aired more than 643,000 times last year to…

  • End of Pandemic-Era Policies in Medicaid Home- and Community-Based Services Could Challenge Family Caregivers and Enrollees

    News Release

    Family caregivers played a key role in supporting people who used Medicaid home- and community-based services (HCBS) during the COVID pandemic. Many states used new pandemic-era authorities to support and pay family caregivers and maintain services in other ways amid workforce shortages and other challenges. Now, several states are ending payments to family caregivers and unwinding other pandemic-era policies, which could complicate ongoing workforce shortages and create new challenges for enrollees, according to survey of…

  • About 1 in 5 Nursing Facilities Would Currently Meet Proposed Requirements for Nursing Staff Hours

    News Release

    Eighty-one percent of nursing facilities would need to hire additional staff to comply with new nursing staff requirements that the Centers for Medicare and Medicaid Services (CMS) proposed earlier this month, according to a new analysis from KFF. Under the proposed rule, 19% of nursing facilities would currently meet the minimum staff hours for registered nurses and nurse aides.A smaller share of for-profit facilities would meet the proposed staffing requirements. Compared to 60% of non-profit…

  • Immigrants Overwhelmingly Say They and Their Children Are Better Off in the US, But Many Also Report Substantial Discrimination and Challenges, a New KFF/Los Angeles Times Survey Reveals

    News Release

    A new KFF-Los Angeles Times partnership survey of immigrant adults – the largest nationally representative survey focused on immigrants – shows that while most feel they found a better life for their families in this country, many also face economic hardships and discrimination. Conducted in partnership with the Los Angeles Times, the survey of more than 3,300 immigrants conducted in 10 languages captures the varied experiences of immigrants living in the United States today, including…

  • Large Shares of Black Adults, Hispanic Adults, and Rural Residents are Unsure Whether to Believe Many False Health Claims  

    News Release

    Drawing on KFF’s Misinformation Pilot Poll, KFF today released three follow-up reports examining exposure to, and belief in, health misinformation among Black adults, Hispanic adults, and rural communities. As with the general public, large shares within each group are uncertain about whether each of 10 false health claims are true or not, describing them as either “probably true” or “probably false.” This uncertainty leaves people vulnerable to misinformation but also provides an opportunity to combat…

  • KFF Examines Challenges in Navigating Coverage for Opill, the First Over-the-Counter Daily Oral Contraceptive Pill, Coming to Market Next Year 

    News Release

    As Opill—the first over-the-counter daily oral contraceptive pill in the United States—is expected to be available for purchase in early 2024, new research conducted by KFF examines barriers to its accessibility for consumers and challenges in providing insurance coverage for it. Based on interviews with nearly 80 representatives from private insurance plans, state Medicaid programs, chain pharmacies, and other key groups, the report provides a deeper view into the operational challenges in expanding access to…

  • Already at Record High, ACA Marketplace Enrollment Could Increase Further

    News Release

    Enhanced Marketplace subsidies have continued to drive up enrollment in the individual market, and the loss of Medicaid coverage by millions of people could contribute to this trend, according to a new KFF analysis. Meanwhile, enrollment in non-ACA-compliant plans is at a record low. As of early 2023, an estimated 18.2 million people have individual market coverage, the highest since 2016. Individual market enrollment grew by about 29% between early 2020 and early 2023 —…

  • Poll: Most Americans Encounter Health Misinformation, and Most Aren’t Sure Whether It’s True or False 

    News Release

    A new KFF survey reveals the broad reach of health misinformation, with at least four in 10 people saying that they’ve heard each of 10 specific false claims about COVID-19, reproductive health, and gun violence. Relatively small shares say that each of those false claims are “definitely true”, ranging from as few as 3% who definitively believe that COVID-19 vaccines have been proven to cause infertility to as many as 18% who definitively believe armed…

  • Drugs Used for Weight Loss Could Cost Americans Much More Than People in Peer Countries

    News Release

    In addition to having the highest obesity rates, the U.S is currently facing significantly higher prices for several major drugs used for weight loss and other health needs, according to a new KFF analysis of the list prices for semaglutide and tirzepatide drugs. Ozempic, which has been approved in the U.S. for diabetes, is more than five times as expensive in the U.S. ($936) as in Japan ($169), which has the second highest list price.…